DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
China · Delayed Price · Currency is CNY 18.08
+0.43 (2.44%)
Jul 13, 2026, 3:00 PM CST
SHA:603233 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 20,101 | 20,066 | 17,151 | 28,359 | 37,585 | 33,307 | |
Market Cap Growth | 8.48% | 17.00% | -39.52% | -24.55% | 12.85% | -35.46% |
Enterprise Value | 19,468 | 20,657 | 20,006 | 31,251 | 40,044 | 35,732 |
Last Close Price | 17.65 | 17.08 | 14.05 | 22.30 | 29.00 | 25.31 |
PE Ratio | 15.64 | 16.25 | 18.75 | 24.31 | 36.29 | 42.10 |
Forward PE | 14.57 | 16.97 | 16.44 | 23.76 | 31.37 | 28.06 |
PS Ratio | 0.73 | 0.73 | 0.65 | 1.16 | 1.77 | 1.99 |
PB Ratio | 2.19 | 2.32 | 2.11 | 3.58 | 5.48 | 5.61 |
P/TBV Ratio | 8.21 | 10.38 | 12.20 | 14.61 | 11.71 | 11.90 |
P/FCF Ratio | 4.98 | 4.13 | 10.55 | 20.59 | 13.81 | 128.08 |
P/OCF Ratio | 4.42 | 3.75 | 5.52 | 8.94 | 10.01 | 21.42 |
PEG Ratio | - | 0.45 | 0.45 | 1.13 | 1.45 | - |
EV/Sales Ratio | 0.71 | 0.75 | 0.76 | 1.27 | 1.89 | 2.13 |
EV/EBITDA Ratio | 5.41 | 8.97 | 10.97 | 9.63 | 22.15 | 27.36 |
EV/EBIT Ratio | 9.38 | 10.15 | 12.93 | 17.40 | 25.18 | 32.45 |
EV/FCF Ratio | 4.82 | 4.25 | 12.30 | 22.69 | 14.71 | 137.41 |
Debt / Equity Ratio | 0.56 | 0.67 | 0.95 | 0.82 | 0.86 | 0.89 |
Debt / EBITDA Ratio | 1.44 | 1.62 | 2.46 | 2.01 | 2.06 | 2.34 |
Debt / FCF Ratio | 1.28 | 1.19 | 4.76 | 4.73 | 2.18 | 20.29 |
Net Debt / Equity Ratio | -0.21 | -0.13 | 0.19 | 0.26 | 0.20 | 0.40 |
Net Debt / EBITDA Ratio | -0.83 | -0.51 | 0.83 | 0.63 | 0.74 | 1.82 |
Net Debt / FCF Ratio | -0.48 | -0.24 | 0.93 | 1.49 | 0.50 | 9.13 |
Asset Turnover | 1.03 | 1.04 | 1.05 | 1.09 | 1.11 | 1.13 |
Inventory Turnover | 4.26 | 4.38 | 4.19 | 3.92 | 3.53 | 3.29 |
Quick Ratio | 0.59 | 0.57 | 0.58 | 0.54 | 0.62 | 0.55 |
Current Ratio | 0.93 | 0.89 | 0.92 | 0.94 | 1.10 | 1.10 |
Return on Equity (ROE) | 15.77% | 16.18% | 12.20% | 16.63% | 16.86% | 13.98% |
Return on Assets (ROA) | 4.84% | 4.81% | 3.83% | 4.99% | 5.21% | 4.64% |
Return on Invested Capital (ROIC) | 20.77% | 17.46% | 11.54% | 14.93% | 14.69% | 15.65% |
Return on Capital Employed (ROCE) | 17.50% | 17.80% | 12.20% | 14.20% | 14.30% | 10.80% |
Earnings Yield | 6.40% | 6.16% | 5.33% | 4.11% | 2.76% | 2.38% |
FCF Yield | 20.08% | 24.24% | 9.48% | 4.86% | 7.24% | 0.78% |
Dividend Yield | 5.55% | 4.86% | 4.41% | 1.39% | 1.72% | 1.37% |
Payout Ratio | 60.51% | 63.31% | 82.34% | 51.82% | 40.58% | 67.53% |
Buyback Yield / Dilution | -0.71% | -1.28% | 0.28% | 0.50% | -0.69% | 0.24% |
Total Shareholder Return | 4.85% | 3.58% | 4.70% | 1.88% | 1.03% | 1.61% |